We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Hyperpolarization Technology Helps MRI Visualize the Origins of Disease

By HospiMedica International staff writers
Posted on 10 Nov 2011
Swedish researchers are now examining molecules that are typically only found in very small concentrations, directly in organs and tissue. More...
After several years of work, researchers in Lund have managed to construct an instrument that “hyperpolarizes” the molecules and thereby makes it possible to track them using magnetic resonance imaging (MRI). The technology creates new possibilities to explore what really occurs on the molecular level in organs such as the brain.

In the polarizer, the researchers created these molecules visible to the MRI scanner by hyperpolarizing them. The molecules are then injected into their natural body tissue. “Then we can follow the specific molecule and see the reactions in which it is involved. This gives us a unique opportunity to see and measure enzymatic reactions directly in the living tissue,” explained Prof. Deniz Kirik, a professor of neuroscience at Lund University (Sweden).

The technology could be utilized to study molecules in many different types of tissue in the body. Prof. Kirik, who is a professor of neuroscience, will focus on developing this technology to study the brain something, which has not been done before. “The brain is not an easy target,” he observed. “When we look inside the brain today using MRI, we see the molecules that are most numerous. However, it is rarely these common molecules we want to study. We want to study how molecules that have a low concentration in the tissue behave, for example, how signal substances are produced, used, and broken down. It is when these processes don’t work that we become ill. This technology has the potential to help us do just that. If we can make it work, it will be a breakthrough not only for neuroscience but also for other research fields such as diabetes, cancer, and inflammation, where similar obstacles limit our understanding of the basic molecular processes which lead to disease.”

Prof. Hindrik Mulder is one of the coapplicants for the project and he will develop and use the technology in diabetes research. Dr. Vladimir Denisov, from the Lund University Bioimaging Center, is leading the technical development within the project.

At present, there are only a few polarizers in the world and Lund’s newly built device is the only one in Scandinavia to be fully available for academic research. “All the other equivalent instruments are purchased commercially and come with restrictions placed by the manufacturer. We therefore chose to take the longer and more complicated route of building the instrument ourselves,” explained Prof. Kirik.

Now that the instrument has become operational, the researchers have started on the first experiments. “This is the first of two steps,” concluded Prof. Kirik. “The next step in this frontline research is to develop the unique technology by constructing an even more sophisticated polarizer that will enable advanced experiments on animal models for various diseases.”

Related Links:
Lund University



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Blood Gas Analyzer
i-Check200
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.